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elderly hypertensive patients systolic pressure should be lowered to 140 mm Hg 12, 14 or 150 mm Hg [13] [14] [15] without stated goal diastolic pressure. Compared with office measurement, home blood pressure monitoring is a better prognosticator because of the greater number of readings, the minimization of the white coat effect, and the unmasking of masked hypertension. 14, 16, 17 According to Japanese guidelines, 17 home blood pressure measurement is useful for preventing an excessive or insufficient antihypertensive effect of drugs. To our knowledge, the Predictive Values of Blood Pressure and Arterial Stiffness in Institutionalized Very Aged Population Study (PARTAGE) 18, 19 is the only survey based on the self-measured blood pressure in octogenarians. High blood pressure did not entail an increased risk of all-cause mortality or major cardiovascular events. In view of the uncertainty about blood pressure targets to be achieved in the very elderly, we assessed the predictive value of the self-measured home blood pressure in octogenarians enrolled in the International Database on Home Blood Pressure in Relation to Cardiovascular Outcome (IDHOCO). 20 In line with the PARTAGE findings, 19 we stratified our analysis according to treatment status.
Methods
Study Population
Expanded Methods available in the online only Data Supplement provide detailed information on the construction of the IDHOCO database 20 and the characteristics of enrolled cohorts (Table S1 in the online-only Data Supplement). For the present analysis, we selected 375 participants aged ≥80 years, of whom 202 were untreated at baseline. Hospitalized, institutionalized, incapacitated, or demented patients were excluded from recruitment. The analysis included 144 (untreated/treated, 106/38) residents of Ohasama, Japan 21 ; 137 (75/62) inhabitants of the Tsurugaya district in Sendai, Japan 22 ; 36 (21/15) inhabitants of Didima, Greece 23 ; and 58 treated outpatients of a general hospital in Buenos Aires, Argentina. 24 All studies received ethical approval. Participants provided written informed consent.
Collection of the Baseline Data
Office blood pressure was the average of 2 readings obtained with a standard mercury sphygmomanometer, 23 or with an automated auscultatory 21 or oscillometric device, 22, 24 using the appropriate cuff size. All home blood pressure measurements were performed in the sitting position with a validated oscillometric device, [21] [22] [23] [24] using the appropriate cuff size. The average of all available home measurements was used in the analysis. Throughout this article, unless otherwise specified, blood pressure refers to the self-measured home blood pressure.
We obtained information on each participant's medical history, use of medications, and smoking and drinking habits by means of questionnaires [21] [22] [23] or checking hospital files. 24 The Expanded Methods in the online only Data Supplement provide information on the collection of anthropometric and biochemical data.
Ascertainment of Events
We ascertained vital status and the incidence of fatal and nonfatal diseases from the appropriate sources in each country (Table S1 ), as described in previous publications. 20 Fatal and nonfatal stroke did not include transient ischemic attacks. Cardiac events comprised fatal and nonfatal myocardial infarction, death caused by ischemic heart disease or other cardiac causes, sudden death, fatal and nonfatal heart failure, coronary revascularization, and pacemaker implantation. The composite cardiovascular end point included cardiovascular mortality and the aforementioned cardiovascular end points. In outcome analyses of composite cardiovascular end points, we only considered the first event in each category.
Statistical Analysis
For database management and statistical analysis, we used SAS software, version 9.3 (SAS Institute Inc, Cary, NC). For comparison of means and proportions, we applied the large sample z-test or ANOVA and the χ 2 statistic, respectively. We compared intercepts and slopes of regression lines between untreated and treated participants by ANCOVA. 25 Statistical significance was a α-level of <0.05 on 2-sided tests.
We applied the deviation from mean coding to compute hazard ratios (HRs) in fifths of the distribution of the home blood pressure. This approach expresses the risk in each fifth relative to the overall risk in the whole study population and allows computing 95% confidence intervals (CIs) for the HRs in all fifths without defining an arbitrary reference group. Next, we used Cox proportional hazards models to compute HRs expressing the risk associated with blood pressure analyzed as continuous variable, while adjusting for cohort, sex, age, body mass index, smoking, drinking alcohol, serum cholesterol, and a history of cardiovascular disease and diabetes mellitus. Fully adjusted models included both systolic and diastolic blood pressures. We checked the proportional hazards assumption and the functional forms of the covariables by the Kolmogorov-type supremum test. We tested heterogeneity in the HRs across subgroups by introducing the appropriate interaction term in the Cox model. We applied the generalized R 2 statistic 26 to assess the risks additionally explained by home blood pressure over and beyond other risk factors. Table 1 shows baseline characteristics of the 202 untreated and 173 treated octogenarians included in IDHOCO. The baseline characteristics of each cohort appear in Tables S3 and S4 for untreated and treated participants, respectively. The median number (5th to 95th percentile interval) of home blood pressure measurements amounted to 48 (8-56) in Ohasama, 10 (2-34) in Tsurugaya, 12 in Didima, and 24 (22) (23) (24) (25) (26) (27) (28) in Buenos Aires. Among treated participants belonging to the Ohasama, Tsurugaya, and Buenos Aires cohorts, 80 (50.6%) were on monotherapy and 78 (49.4%) were on combination therapy taking a median of 1.0 drug per day. In treated participants of these 3 cohorts, 37 (23.4%) used diuretics, 40 (25.3%) β-blockers, 33 (20.9%) angiotensin-converting enzyme inhibitors, 38 (24.1%) angiotensin-II type-1 receptor blockers, 113 (71.5%) calcium-channel blockers, and 22 (13.9%) other various classes of antihypertensive agents. Information on drugs use was unavailable from the Didima cohort.
Results
Characteristics of Participants
of cardiovascular disease and diabetes mellitus, the risk across fifths of the distribution of blood pressure versus the average risk in all untreated octogenarians ( Figure 1) by adding diastolic pressure to the model already including the other risk factors ranged from 1.54% to 2.36% for cardiovascular mortality and cardiac events, respectively (Table 3) . Systolic pressure added only from 0.01% to 0.21% on top of the basic model, not reaching significance. Figure 2 shows the 5-year risk of cardiovascular events associated with systolic or diastolic pressure analyzed as continuous variables and across percentiles (10th, 50th, and 90th) of the alternative component of home blood pressure in untreated octogenarians. The association was significant for diastolic blood pressure (P=0.039). The findings were similar for cardiovascular mortality ( Figure S1 ).
Analysis of Treated Participants
Incidence of End Points
Among 173 untreated octogenarians, median follow-up was 5.3 years (5th to 95th percentile interval, 1.2-11.8 years). Over 900 person-years of follow-up, 52 participants died (57.8 per Hazard ratios express the risk associated with a 1-SD increase in blood pressure (given between parentheses in column headings). All models were adjusted for cohort, sex, age, body mass index, smoking and drinking, serum cholesterol, and history of cardiovascular disease and diabetes mellitus. Adjusted models include either systolic pressure or diastolic pressure, while fully adjusted models include both systolic and diastolic blood pressure in addition to other covariables. In treated participants, the relation of cardiovascular events with systolic pressure was curvilinear and is reported separately in the Results section of this article and 
Risk Associated With Home Blood Pressure
The analyses were adjusted as in the untreated participants.
The risk of all-cause mortality versus the average risk in all treated participants was higher in the lower fifth of the distribution of systolic pressure (<126.9 mm Hg; HR, 2.09; 95% CI, 1.10-3.98; P=0.020; Figure S2 ). Figure 3 , in treated participants, the relationship between all cardiovascular events and systolic blood pressure was U shaped with the nadir at 148.6 mm Hg. The risk was standardized to the distribution in the whole untreated population (ratio or mean) of cohort, sex, age, body mass index, smoking and drinking, serum cholesterol, and history of cardiovascular disease and diabetes mellitus. P S and P D indicate the significance of the association with systolic and diastolic home blood pressure, respectively. Decreasing the nadir by 1 SD (18.1 mm Hg), increased the risk for a cardiovascular event by 45% (1% to 108%; P=0.046) in the adjusted model and by 45% (−3% to 116%; P=0.071) in the fully adjusted model. The corresponding estimates for a 1-SD increment in systolic blood pressure above the nadir were 44% (−12% to 103%; P=0.092) and 44% (−15% to 104%; P=0.112), respectively.
5-year risk (%)
The increase in the generalized R 2 by adding systolic blood pressure to the model already including the other risk factors ranged from 2.92% to 3.91% for all-cause mortality and cardiovascular and cardiac events (Table 3) . Diastolic blood pressure added only from 0.02% to 0.81% on top of the basic model, not reaching significance.
Sensitivity Analyses
We checked the consistency of our results for all-cause and cardiovascular mortality (Table S5 ) and for the combination of fatal and nonfatal cardiovascular events (Table S6) according to sex and ethnicity. For untreated (0.083≤P≤0.68) and treated (0.096≤P≤0.96) participants, the HRs were not statistically different across strata. Tables S7 and S8 show the HRs obtained after excluding one cohort at a time for untreated and treated participants, respectively. Statistical significance was mainly driven by the Ohasama cohort with the largest number of events. However, all HRs were within the 95% CI for all available participants. Thus, no cohort had an excessive influence on the estimate based on all participants combined.
Finally, in untreated and treated participants, ANCOVA showed that the regression lines relating office with home blood pressure were coincident (P values for differences in slopes and intercepts ≥0.10). In all participants (Figure 4) , a home blood pressure of 127 mm Hg systolic and 65 mm Hg diastolic corresponded with office blood pressures of 136.3 mm Hg (95% CI, 134.0-138.6 mm Hg) and 72.0 mm Hg (95% CI, 70.6-73.5 mm Hg), respectively.
Discussion
Current guidelines for diagnosis and management of hypertension provide either no special recommendations for the very elderly 27, 28 or recommendations exclusively based on office blood pressure. [12] [13] [14] [15] Our current study provides preliminary thresholds for the self-measured blood pressure in risk stratification among the very elderly. In untreated participants, a home blood pressure >150 mm Hg (rounded) or <65 mm Hg (rounded) conferred an increased risk of a cardiovascular death or a composite cardiovascular end point, whereas a diastolic home pressure >80 mm Hg was associated with low cardiovascular mortality. These findings are in line with the vast epidemiological knowledge database showing that in the elderly a wide pulse pressure, an index of arterial stiffness, is associated with a dire prognosis. 29 In treated octogenarians, there was a curvilinear association between cardiovascular risk and systolic home blood pressure, independent from diastolic pressure, with nadir at ≈150 mm Hg. The risk of death or a cardiovascular event increased below a systolic home pressure of ≈130 mm Hg.
Only one prior study in the very elderly, PARTAGE, addressed the association of cardiovascular risk with the selfmeasured blood pressure in the very elderly.
18, 19 The study included 1127 frail nursing home residents (78.1% women; mean age, 87.6 years). Among 227 PARTAGE participants with low home systolic pressure (<130 mm Hg) on combination antihypertensive treatment (≥2 drugs) compared with the 900 others, home blood pressure averaged 119/65 mm Hg versus 142/75 mm Hg with mortality rates of 32.2% versus 19.7%, respectively. The HRs for all-cause mortality and cardiovascular events associated with low blood pressure were 1.36 (95% CI, 1.06-1.75) and 1.28 (95% CI, 0.99-1.65). 19 In another analysis of the same cohort, 18 patients with a diastolic home blood pressure ranging from 49.3 to 68.5 mm Hg had a 2-year shorter survival than those with higher levels (P=0.021).
Other cohort studies in the very elderly addressed the risk associated with office blood pressure. 30, 31 In Tampere, Finland, 561 octogenarians (82% women; mean age, 88.4 years) were stratified according to systolic (from <120 to >200 mm Hg) or diastolic (from <70 to >110 mm Hg) blood pressure and followed up for 5 years. 30 The strong point of this study was that the population was representative of both fit and frail individuals because they were living either at their home (n=272) or were institutionalized or had been hospitalized (n=289). The key finding was that mortality was highest in the low blood pressure group (<120/70 mm Hg) and lowest in subjects with office blood pressure levels in excess of 160/90 mm Hg. A retrospective cohort study enrolled 4071 hypertensive octogenarians at 10 US Department of Veterans Affairs sites (3.4% women; mean age, 82.6 years). 31 Follow-up spanned 5 years. The association between survival and treated blood pressure was U shaped. Lowering blood pressure <140 mm Hg systolic or 90 mm Hg diastolic was associated with shorter survival. The HRs for a 10-mm Hg increase in blood pressure were 0.84 (95% CI, 0.78-0.89) systolic and 0.91 (95% CI, 0.87-0.96) diastolic, suggesting that aggressive treatment might be harmful at very old age. 31 The HYVET trial, 11 enrolled 3845 physically fit patients (60.5% women; mean age, 83.6 years). The blood pressure at enrolment averaged 173/91 mm Hg. Eligible patients were aged ≥80 years and had a sustained systolic pressure of ≥160 mm Hg. They were randomized to receive either indapamide or matching placebo with the possible addition of perindopril or matching placebo to achieve a target blood pressure of 150/80 mm Hg. 11 At median follow-up (1.8 years), blood pressure was 15.0/6.1 mm Hg lower in the active-treatment group than in the placebo. In the intention-to-treat analysis, 11 reductions in the rates were 30% for fatal or nonfatal stroke (95% CI, −1 to 51), 39% for fatal stroke (95% CI, 1-62), 21% for total mortality (95% CI, 4-35), 23% for cardiovascular mortality (95% CI, −1 to 40), and 64% for heart failure (95% CI, 42-78). HYVET 11 did not provide information on whether a further reduction of office blood pressure would be beneficial and was not representative of the oldest old in whom physical or cognitive disabilities are common.
Current recommendations for the target office blood pressure in very elderly hypertensive patients are ambiguous. The American College of Cardiology Foundation/American Heart Association expert consensus document 12 suggests an office systolic pressure of 140 to 145 mm Hg if tolerated. It states that levels <130/65 mm Hg should be avoided. The European guidelines 14 recommend that those with an office systolic of ≥160 mm Hg should be considered for treatment if considered fit. The target systolic pressure should be <140 mm Hg, or between 140 and 150 mm Hg, according to the level of fitness. Both the Canadian 13 and International 15 guidelines recommend systolic office pressure levels <150 mm Hg without mentioning a diastolic threshold. All guidelines, including one especially focusing on the home blood pressure, 32 suggest a self-measured threshold of 135 mm Hg systolic or 85 mm Hg diastolic irrespective of age.
Strong points of our current report are the involvement of old individuals living in 4 different countries, a followup of >5 years, and the high albeit variable number of home measurements with medians ranging across cohorts from 10 to 48. On the contrary, our study has some potential limitations. First, the sample size was relatively small, but very old people only represent 1.5% of the population and are difficult to recruit. 2 Second, one should be cautious in extrapolating our current findings to other ethnic groups, especially blacks, to populations in which the prevalence of obesity is rampant, or even to the general Japanese or European population. Indeed, our analyses comprised mainly slender Japanese and whites with body mass index averaging 23.0 and 27.1 kg/m 2 , respectively. Finally, methods of ascertaining events and measurements were not identical among cohorts. However, we adjusted for cohort in the Cox proportional hazards models, and our findings remained consistent when we excluded one cohort at a time.
Perspectives
Notwithstanding potential limitations, our current study might have implications for clinical practice. We provide for the first time a reference frame for home blood pressure that may prevent overtreatment by avoiding decreasing home blood pressures <125 to 130 mm Hg. In untreated patients, physicians should be aware that home diastolic pressure levels <65 mm Hg are associated with a worse cardiovascular prognosis, whereas values above ≈80 mm Hg predict a better outcome. These results do not contradict current recommendations for the management of office blood pressure in the very elderly. However, they differ from the recommendations for the management of home blood pressure that suggest the same threshold irrespective of age. 32 A rounded home blood pressure of 125 mm Hg systolic or 65 mm Hg diastolic corresponded with office blood pressures of ≈135 systolic and 70 mm Hg diastolic. Our study, therefore, provides indirect information on the thresholds for office blood pressure that might be optimal in the very elderly.
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• In octogenarians, the optimal self-measured blood pressure (BP) has not yet been established. Guidelines only provide recommendations for office BP based on clinical trials not representative for the general population and with short follow-up. We, therefore, analyzed 375 octogenarians enrolled in the International Database on HOme blood pressure in relation to Cardiovascular Outcome, who were followed up for 5.5 years (median).
What Is Relevant?
• In untreated octogenarians, a home diastolic BP of <65 mm Hg predicted increased cardiovascular events.
• In untreated octogenarians, a home systolic pressure exceeding 150 mm Hg worsened cardiovascular risk.
• In treated octogenarians, a home systolic BP <125 mm Hg was associated with increased total mortality.
• In treated octogenarians, home systolic pressure showed a U-shaped pattern for cardiovascular events with nadir ≈150 mm Hg.
Summary
In untreated octogenarians, low home diastolic pressure should be considered before antihypertensive therapy is initiated. In treated octogenarians, overtreatment should be avoided by not lowering the home systolic pressure to <125 mm Hg.
Outcome ( 
Defining Thresholds for Home Blood Pressure Monitoring in Octogenarians
Expanded Methods
Study Population
At the time of writing this report, IDHOCO 1,2 included 8912 participants recruited in the framework of six prospective population studies [3] [4] [5] [6] [7] [8] and one cohort study mainly including hypertensive patients 9 (Table S1 ). All studies received ethical approval and have been described in peer-reviewed publications. Hospitalized, institutionalized or incapacitated patients were excluded from recruitment. We discarded one cohort because data on causespecific mortality was still being collected 8 and two cohorts because they did not include octogenarians. 4, 7 Among the remaining 4704 participants, 375 were aged 80 years or over, had at least two home blood pressure readings, and known status for antihypertensive treatment. Therefore, the number of analyzed participants totaled 375, of whom at enrolment 202 were untreated and 173 were taking antihypertensive drugs. They included 144 (untreated/treated, 106/38) residents of Ohasama, Japan; 3 137 (75/62) inhabitants of the Tsurugaya district in Sendai, Japan; 6 36 (21/15) inhabitants of Didima, Greece; 5 and 58 treated outpatients of a general hospital in Buenos Aires, Argentina. 9
Blood Pressure Measurement
Office blood pressure was the average of two readings obtained with a standard mercury sphygmomanometer, 5 or with an automated auscultatory 3, 5, 9 or oscillometric device, 6,9 using the appropriate cuff size, with the participants resting in the sitting 3 or supine 6 position. In each cohort, researchers implemented a quality assurance program for home blood pressure monitoring. Doctors, 3,6 nurses 3 or specially trained technicians 9 first explained the rationale of blood pressure self-monitoring. Participants obtained the home blood pressure readings on the left arm after they had rested for 1 to 5 minutes in the sitting position. The automated or semi-automated devices used for office [10] [11] [12] and home 11,13,14 blood pressure measurement had all been validated. Further details on the devices and the procedures for office and home blood pressure measurements appear in Table S2 . In all cohorts morning measurements were obtained within 1 hour of waking up, before breakfast, and if applicable, before the intake of medications. The average of all available measurements at home, at least two, was used in the analysis. Throughout this manuscript, unless specified otherwise, blood pressure refers to the self-measured home blood pressure.
Other Measurements
We obtained information on each participant's medical history, use of medications, and smoking and drinking habits by means of questionnaires 3, 5, 6 or checking hospital files. 9 Body mass index was body weight in kilograms divided by height in meters squared. Serum cholesterol and blood glucose were measured by automated enzymatic methods. As described previously, 1 information on serum total cholesterol level was unavailable for the Didima population and was extrapolated from data provided by the Attica study investigators by sex and 10-year age strata. 15 The Attica study population was a large population cohort examined at the same time (2001) (2002) and in the same geographical area as the Didima cohort. Diabetes mellitus was the use of antidiabetic drugs, a self-reported diagnosis or a fasting or random blood glucose concentration of at least 7.0 mmol/L (126 mg/dL) 16 or 11.1 mmol/L (200 mg/dL), 16 respectively. 
Ascertainment of Events
We ascertained vital status and the incidence of fatal and nonfatal diseases from the appropriate sources in each country (Table S1 ), as described in previous publications. 1,2 Fatal and nonfatal stroke did not include transient ischemic attacks. Cardiac events comprised fatal and nonfatal myocardial infarction, death due to ischemic heart disease or other cardiac causes, sudden death, fatal and nonfatal heart failure, surgical or percutaneous coronary revascularization, and pacemaker implantation. The composite cardiovascular endpoint included cardiovascular mortality and the aforementioned cardiovascular endpoints. In outcome analyses of composite cardiovascular endpoints, we only considered the first event in each category.
Statistical Analysis
For database management and statistical analysis, we used SAS software, version 9.3 (SAS Institute Inc., Cary, NC, USA). For comparison of means and proportions, we applied the large sample z-test or analysis of variance and the  2 statistic, respectively. We compared intercepts and slopes of regression lines between untreated and treated participants by analysis of covariance. 17 Statistical significance was a α-level of less than 0.05 on two-sided tests.
We applied the deviation from mean coding to compute hazard ratios in fifths of the distribution of the home blood pressure. This approach expresses the risk in each fifth relative to the overall risk in the whole study population and allows computing 95% confidence intervals for the hazard ratios in all fifths without defining an arbitrary reference group. Next, we used Cox proportional hazards models to compute hazard ratios expressing the risk associated with blood pressure analyzed as continuous variable, while adjusting for cohort , sex, age, body mass index, smoking, drinking alcohol, total serum cholesterol, and a history of cardiovascular disease and diabetes mellitus. Fully adjusted models included both systolic and diastolic blood pressures. We checked the proportional hazards assumption and the functional forms of the covariables by the Kolmogorov-type supremum test, as implemented in the ASSESS statement of the PROC PHREG procedure of the SAS package. We tested heterogeneity in the hazard ratios across subgroups by introducing the appropriate interaction term in the Cox model. We applied the generalized R 2 statistic 18 to assess the risks additionally explained by home blood pressure over and beyond other risk factors. Abbreviations: CI, confidence interval; n/N, number of deaths/number of participants at risk; BP, blood pressure. Hazard ratios express the risk associated with a 1-SD increase in blood pressure (given between parentheses in column headings). All models include both systolic and diastolic pressure and were adjusted for cohort, sex, age, body mass index, smoking and drinking, serum cholesterol, history of cardiovascular disease and diabetes mellitus. Hazard ratios did not differ between strata (P≥0.075). An ellipsis indicates that the model did not converge. Abbreviations: CI, confidence interval; n/N, number of events/number of participants at risk; BP, home blood pressure. Hazard ratios express the risk associated with a 1-SD increase in blood pressure (given between parentheses in column headings). All models include both systolic and diastolic pressure and were adjusted for cohort, sex, age, body mass index, smoking and drinking, serum cholesterol, history of cardiovascular disease and diabetes mellitus. Hazard ratios did not differ between strata (P≥0.075). An ellipsis indicates that the model did not converge. Abbreviations: CI, confidence interval; n/N, number of events/number of participants at risk; BP, home blood pressure. Hazard ratios express the risk associated with a 1-SD increase in blood pressure (given between parentheses in column headings). All models include both systolic and diastolic pressure and were adjusted for cohort, sex, age, body mass index, smoking and drinking, serum cholesterol, history of cardiovascular disease and diabetes mellitus. Abbreviations: CI, confidence interval; n/N, number of events/number of participants at risk; BP, home blood pressure. Hazard ratios express the risk associated with a 1-SD increase in home blood pressure (given between parentheses in column headings). All models include both systolic and diastolic pressure and were adjusted for cohort, sex, age, body mass index, smoking and drinking, serum cholesterol, history of cardiovascular disease and diabetes mellitus.
-Page 15 of 16- Figure S1 . Five-year risk of cardiovascular mortality associated with systolic (A) or diastolic (B) home blood pressure analyzed as continuous variables and across percentiles (5th, 50th and 95th) of the alternative component of blood pressure in 202 untreated octogenarians. The risk was standardized to average of the distribution in the whole untreated population (ratio or mean) of cohort, sex, age, body mass index, smoking and drinking, serum cholesterol, history of cardiovascular disease and diabetes mellitus. P S and P D indicate the significance of the association with systolic and diastolic home blood pressure, respectively.
-Page 16 of 16- Figure S2 . Multivariable-adjusted hazard ratios for total mortality by fifths of the distribution of the systolic home blood pressure in 173 treated octogenarians. The hazard ratios express the risk in fifths compared with average risk in all treated participants and were adjusted for cohort, sex, age, body mass index, smoking and drinking, serum cholesterol, history of cardiovascular disease and diabetes mellitus. The point estimates, 95% confidence interval and P-value are provided for the hazard ratio that significantly deviated from the reference at systolic levels below 126.9 mm Hg.
